In the present study, we for the first time performed a genetic analysis of FH causative mutations in consecutive 105 very early-onset CAD patients (≤ 35 years), with plasma LDL-C ≥ 3.4 mmol/L. This evidence concerns the gene FH and coronary artery disorder.